Sixth Annual Biotech Showcase™ returns to San Francisco January 13–15

The sixth annual Biotech Showcase™ investor and partnering conference will be held January 13–15, 2014 in San Francisco, CA at Parc 55 Wyndham San Francisco – Union Square. The event is an established innovation showcase for life science investors. Executive-level delegates representing top public and private investment firms come with the single aim to partner with emerging biotechnology and life science companies.

Confirmed speakers include Ron Cohen of Acorda Therapeutics, Dennis Purcell of Aisling Capital, Marc Dunoyer of AstraZeneca, Bruce Booth of Atlas Venture, Karen Bernstein ofBioCentury, Evan McCulloch of Franklin Resources, James Sabry of Genentech, Melinda Richter of Janssen Research &Development, Iain Dukes of Merck, Anton Gopka of RusnanoMedInvest, Alex Zisson of Thomas, McNerney &Partners, and more.

“This is the place where biotech companies should present,” said Dennis Purcell, Senior Managing Director of Aisling Capital. “You have the largest gathering of investor decision-makers converging on San Francisco in January, and Biotech Showcase is where they come to meet high-growth, high-innovation, high-caliber biotech innovation and see firsthand the exciting science being worked on in the industry. This is becoming the new H&Q.”

Biotech Showcase is co-produced annually by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of providing high quality business support programs and services to the biotechnology industry.

“Biotech Showcase puts investors and strategic partners face-to-face with emerging companies and biotech and healthcare innovators,” said Sara Jane Demy, CEO of Demy-Colton Life Science Advisors. “Investor registrations are up this year. Buoyed by the current environment, these are real investors looking to invest in companies that have excellent science and a compelling story. You won’t find another event that has such a high level of quality and expertise in terms of the investment teams that attend.”

Florian Schoenhammer, Group Managing Director of EBD Group, said, “This is a unique forum, in that it consistently draws high caliber executives from private and public companies. There is tangible excitement for the event in the biotech sector, because this is where groundwork is laid for the deals that will take place during the year.”

Participants include private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives as well as other industry professionals. The 2014 edition is expected to attract 1,900 attendees and will feature nearly 300 corporate presentations as well as a robust program that will address the current environment for investment and financing, progress in disease areas and business development trends.

Biotech Showcase is powered by partneringONE®, the industry’s most advanced partnering system that enables delegates to efficiently identify and arrange meetings with potential investors and partners.

Companies interested in requesting a presentation slot can do so online

Register before November 22 and save USD 200.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
  • EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
  • The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit

About Biotech Showcase™ 2014

Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.

The 2013 edition showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. The 2013 event featured corporate presentations by 236 public and private biotechnology and life science companies, and drew 1,600 delegates who engaged in 2,500 one-to-one meetings.

Follow Biotech Showcase 2014 on Twitter: (hashtag: #BTS14)